NPAS2 and hepatocellular carcinoma: A recent study has shown that upregulated NPAS2 promoted the survival of hepatocellular carcinoma cells through the upregulation of cell division cycle 25 A (CDC25A) and inhibition of mitochondria-dependent intrinsic apoptosis (Yuan et al., 2017).